Center Laboratories Inc. - Net Worth and Insider Trading
Center Laboratories Inc. Net Worth
The estimated net worth of Center Laboratories Inc. is at least $427 Million dollars as of 2024-09-23. Center Laboratories Inc. is the 2101 Beneficial owner of TOT Biopharm International Co Ltd and owns about 213,311,700 shares of TOT Biopharm International Co Ltd (HKSE:01875) stock worth over $427 Million. Details can be seen in Center Laboratories Inc.'s Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Center Laboratories Inc. has not made any transactions after 2022-07-29 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Center Laboratories Inc.
Center Laboratories Inc. Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Center Laboratories Inc. owns 1 companies in total, including TOT Biopharm International Co Ltd (HKSE:01875) .
Click here to see the complete history of Center Laboratories Inc.’s form 4 insider trades.
Insider Ownership Summary of Center Laboratories Inc.
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
HKSE:01875 | TOT Biopharm International Co Ltd | 2022-07-29 | 2101 Beneficial owner |
Center Laboratories Inc. Latest Holdings Summary
Center Laboratories Inc. currently owns a total of 1 stock. Center Laboratories Inc. owns 213,311,700 shares of TOT Biopharm International Co Ltd (HKSE:01875) as of July 29, 2022, with a value of $427 Million.
Latest Holdings of Center Laboratories Inc.
Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
HKSE:01875 | TOT Biopharm International Co Ltd | 2022-07-29 | 213,311,700 | 2.00 | 426,623,400 |
Holding Weightings of Center Laboratories Inc.
Center Laboratories Inc. Form 4 Trading Tracker
According to the SEC Form 4 filings, Center Laboratories Inc. has made a total of 2 transactions in TOT Biopharm International Co Ltd (HKSE:01875) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in TOT Biopharm International Co Ltd is the acquisition of 33,750,000 shares on July 29, 2022, which cost Center Laboratories Inc. around $0.
Insider Trading History of Center Laboratories Inc.
- 1
Center Laboratories Inc. Trading Performance
GuruFocus tracks the stock performance after each of Center Laboratories Inc.'s buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Center Laboratories Inc. is -18.65%. GuruFocus also compares Center Laboratories Inc.'s trading performance to market benchmark return within the same time period. The performance of stocks bought by Center Laboratories Inc. within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Center Laboratories Inc.'s insider trading performs compared to the benchmark.
Performance of Center Laboratories Inc.
Center Laboratories Inc. Ownership Network
Center Laboratories Inc. Owned Company Details
What does TOT Biopharm International Co Ltd do?
Who are the key executives at TOT Biopharm International Co Ltd?
Center Laboratories Inc. is the 2101 Beneficial owner of TOT Biopharm International Co Ltd. Other key executives at TOT Biopharm International Co Ltd include 2201 Interest of corporation controlled by you Center Laboratories, Inc. , 2301 Trustee Tricor Trust (hong Kong) Limited , and 2101 Beneficial owner Chengwei Evergreen Capital, LP .
TOT Biopharm International Co Ltd (HKSE:01875) Insider Trades Summary
Over the past 18 months, Center Laboratories Inc. made no insider transaction in TOT Biopharm International Co Ltd (HKSE:01875). Other recent insider transactions involving TOT Biopharm International Co Ltd (HKSE:01875) include a net sale of 0 shares made by Center Laboratories, Inc. ,
In summary, during the past 3 months, insiders sold 0 shares of TOT Biopharm International Co Ltd (HKSE:01875) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of TOT Biopharm International Co Ltd (HKSE:01875) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
TOT Biopharm International Co Ltd (HKSE:01875)'s detailed insider trading history can be found in Insider Trading Tracker table.
TOT Biopharm International Co Ltd Insider Transactions
Center Laboratories Inc. Mailing Address
Above is the net worth, insider trading, and ownership report for Center Laboratories Inc.. Currently GuruFocus does not have mailing address information for Center Laboratories Inc..